Codiak BioSciences

https://www.codiakbio.com/pipeline-programs/pipeline

https://old.nasdaq.com/de/symbol/cdak/real-time

https://www.finanznachrichten.de/...aktien/codiak-biosciences-inc.htm  

 

to be Moderna 2.0

https://kametresearch.com/...cor-and-codiak-poised-to-be-moderna-2-0/  

Umsatz verachtfacht, Verlust verringert, das sieht doch alles ganz ordentlich aus...

http://www.globenewswire.com/news-release/2021/03/...al-Progress.html  

übertrieben, habe daher 400 Stück zu EUR 11,90 nachgelegt...  

 

https://www.americanbankingnews.com/2021/04/17/...-william-blair.html  

https://www.nasdaq.com/de/market-activity/stocks/cdak/real-time  

https://www.finanzen.net/aktien/codiak_biosciences-aktie@stBoerse_NDB  

https://www.globenewswire.com/news-release/2021/...tions-Biology.html  

 

 

wir haben noch nicht mal den Monatsverlust kompensiert (immer noch - 7,4 Prozent)  

https://www.nasdaq.com/de/market-activity/stocks/cdak/real-time  

 

 

 

https://www.nasdaq.com/de/market-activity/stocks/cdak/real-time  

https://www.marketwatch.com/investing/stock/cdak/analystestimates  

 

https://www.globenewswire.com/news-release/2021/...-of-Directors.html  

In company news, Codiak BioSciences (CDAK) rose almost 1% after the biopharmaceuticals company Tuesday said it was eliminating about 37% of its current workforce, leaving 53 full-time employees on its payroll. The company, which finished the June quarter with around $41.8 million in cash and equivalents, also said it was exploring potential partnerships to help extend its cash runway.

https://www.nasdaq.com/articles/...08-30-2022%3A-cdakbxrxamambgxxabti  

https://www.nasdaq.com/de/market-activity/stocks/cdak/analyst-research  

https://ir.codiakbio.com/news-releases/...ublic-offering-common-stock  

Chapter 11

https://ir.codiakbio.com/news-releases/...e-through-voluntary-chapter

 

Das ging hier schnell runter!